Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2356
mi
from 98109
Raleigh, NC
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2356
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1966
mi
from 98109
Cincinnati, OH
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1519
mi
from 98109
Oklahoma City, OK
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1519
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2285
mi
from 98109
Chester, SC
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2285
mi
from 98109
Chester, SC
Click here to add this to my saved trials
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2263
mi
from 98109
Clinton, SC
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2263
mi
from 98109
Clinton, SC
Click here to add this to my saved trials
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2351
mi
from 98109
Orangeburg, SC
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2351
mi
from 98109
Orangeburg, SC
Click here to add this to my saved trials
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
5265
mi
from 98109
Gauting,
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
5265
mi
from 98109
Gauting,
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2148
mi
from 98109
Mobile, AL
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2148
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
987
mi
from 98109
Huntington Beach, CA
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
987
mi
from 98109
Huntington Beach, CA
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2725
mi
from 98109
Aventura, FL
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2725
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2730
mi
from 98109
Miami, FL
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1993
mi
from 98109
Sunset, LA
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1993
mi
from 98109
Sunset, LA
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2327
mi
from 98109
Baltimore, MD
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2327
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2512
mi
from 98109
North Dartmouth, MA
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2512
mi
from 98109
North Dartmouth, MA
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1392
mi
from 98109
Minneapolis, MN
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1392
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1381
mi
from 98109
Plymouth, MN
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1381
mi
from 98109
Plymouth, MN
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2281
mi
from 98109
Charlotte, NC
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1519
mi
from 98109
Oklahoma City, OK
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1519
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
367
mi
from 98109
Medford, OR
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
367
mi
from 98109
Medford, OR
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
2269
mi
from 98109
Union, SC
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2269
mi
from 98109
Union, SC
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1776
mi
from 98109
San Antonio, TX
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1776
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
1723
mi
from 98109
Waco, TX
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1723
mi
from 98109
Waco, TX
Click here to add this to my saved trials
Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma
Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma
Status: Enrolling
Updated:  10/9/2017
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma
Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma
Status: Enrolling
Updated: 10/9/2017
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Adiposity and Airway Inflammation in HIV-Associated Airway Disease
Adiposity and Airway Inflammation in HIV-Associated Airway Disease
Status: Enrolling
Updated:  10/11/2017
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Adiposity and Airway Inflammation in HIV-Associated Airway Disease
Adiposity and Airway Inflammation in HIV-Associated Airway Disease
Status: Enrolling
Updated: 10/11/2017
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Exercise and Asthma in Obese Adults
Effects of Aerobic Exercise on Asthmatic Responses in Obese Adults
Status: Enrolling
Updated:  10/13/2017
The University of Arizona and the Tucson Unified School District
1221
mi
from 98109
Tucson, AZ
Exercise and Asthma in Obese Adults
Effects of Aerobic Exercise on Asthmatic Responses in Obese Adults
Status: Enrolling
Updated: 10/13/2017
The University of Arizona and the Tucson Unified School District
1221
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
The Effect of Salmeterol on Eosinophil (EOS) Function
The Effect of Salmeterol on Eosinophil (EOS) Function
Status: Enrolling
Updated:  10/17/2017
University of Wisconsin
1616
mi
from 98109
Madison, WI
The Effect of Salmeterol on Eosinophil (EOS) Function
The Effect of Salmeterol on Eosinophil (EOS) Function
Status: Enrolling
Updated: 10/17/2017
University of Wisconsin
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Imaging Study of the Lungs During an Allergic Asthma Attack
Redistribution of Pulmonary Perfusion During Bronchoconstriction in Asthma
Status: Enrolling
Updated:  10/19/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Imaging Study of the Lungs During an Allergic Asthma Attack
Redistribution of Pulmonary Perfusion During Bronchoconstriction in Asthma
Status: Enrolling
Updated: 10/19/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma
Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma
Status: Enrolling
Updated:  10/20/2017
Human Research Laboratory- University of Miami School of Medicine
2730
mi
from 98109
Miami, FL
Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma
Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma
Status: Enrolling
Updated: 10/20/2017
Human Research Laboratory- University of Miami School of Medicine
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
University of Alabama
2079
mi
from 98109
Birmingham, AL
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
University of Alabama
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Contra Costa Health Services (East and West Contra Costa)
664
mi
from 98109
Martinez, CA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Contra Costa Health Services (East and West Contra Costa)
664
mi
from 98109
Martinez, CA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Southeast Health Center
680
mi
from 98109
San Francisco, CA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Southeast Health Center
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Santa Clara Health Center
713
mi
from 98109
San Jose, CA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Santa Clara Health Center
713
mi
from 98109
San Jose, CA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Yale Primary Care Center
2432
mi
from 98109
New Haven, CT
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Yale Primary Care Center
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
East Baltimore Medical Center
2328
mi
from 98109
Baltimore, MD
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
East Baltimore Medical Center
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Boston Healthcare for the Homeless Program
2485
mi
from 98109
Boston, MA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Boston Healthcare for the Homeless Program
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Montefiore Transition Clinic
2403
mi
from 98109
New York, NY
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Montefiore Transition Clinic
2403
mi
from 98109
New York, NY
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Medicine in Psychiatry Service clinic of the University of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Medicine in Psychiatry Service clinic of the University of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Corporacion SANOS
3738
mi
from 98109
Caguas,
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Corporacion SANOS
3738
mi
from 98109
Caguas,
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Morningside Clinic
2262
mi
from 98109
New York, NY
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Morningside Clinic
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Positive Expiratory Pressure for the Treatment of Acute Asthma in Children
Positive Expiratory Pressure for the Treatment of Acute Asthma Exacerbations in Children: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/6/2017
Children's Hospital Colorado
1029
mi
from 98109
Aurora, CO
Positive Expiratory Pressure for the Treatment of Acute Asthma in Children
Positive Expiratory Pressure for the Treatment of Acute Asthma Exacerbations in Children: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/6/2017
Children's Hospital Colorado
1029
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site
990
mi
from 98109
Huntington Beach, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site
990
mi
from 98109
Huntington Beach, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 10503
998
mi
from 98109
Mission Viejo, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 10503
998
mi
from 98109
Mission Viejo, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 10140
984
mi
from 98109
Orange, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 10140
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 10242
979
mi
from 98109
Rolling Hills Estates, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 10242
979
mi
from 98109
Rolling Hills Estates, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site
1065
mi
from 98109
San Diego, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site
1065
mi
from 98109
San Diego, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 10179
711
mi
from 98109
San Jose, CA
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 10179
711
mi
from 98109
San Jose, CA
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 1315
1030
mi
from 98109
Centennial, CO
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 1315
1030
mi
from 98109
Centennial, CO
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 10172
1067
mi
from 98109
Colorado Springs, CO
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 10172
1067
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  11/7/2017
Teva Investigational Site 1298
2552
mi
from 98109
Sarasota, FL
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 11/7/2017
Teva Investigational Site 1298
2552
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials